Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Amiridin
2. Amiridine
3. Axamon
4. Neuromidin
5. Nik 247
6. Nik247
1. 62732-44-9
2. Amiridine
3. 2,3,5,6,7,8-hexahydro-1h-cyclopenta[b]quinolin-9-ylamine
4. 2,3,5,6,7,8-hexahydro-1h-cyclopenta[b]quinolin-9-amine
5. Ipidacrine [inn]
6. Cv71vtp0vn
7. 9-amino-2,3,5,6,7,8-hexahydro-1h-cyclopenta(b)quinoline
8. 1h-cyclopenta(b)quinolin-9-amine, 2,3,5,6,7,8-hexahydro-
9. Chembl130880
10. 2,3,5,6,7,8-hexahydro-1h-cyclopenta(b)quinolin-9-amine
11. 1h,2h,3h,5h,6h,7h,8h-cyclopenta[b]quinolin-9-amine
12. 1h-cyclopenta[b]quinolin-9-amine, 2,3,5,6,7,8-hexahydro-, Monohydrochloride- [cas]
13. 9-amino-2,3,5,6,7,8-hexahydro-1h-cyclopenta[b]quinoline
14. 1h-cyclopenta[b]quinolin-9-amine, 2,3,5,6,7,8-hexahydro-
15. Smr000449322
16. Unii-cv71vtp0vn
17. Brn 0475930
18. Cpd000449322
19. Ipidacrine [mi]
20. Ipidacrine [mart.]
21. Ipidacrine [who-dd]
22. Oprea1_177774
23. Oprea1_388798
24. Schembl28251
25. Cbdive_008152
26. Mls000758231
27. Mls001423960
28. Dtxsid7048299
29. Nik(c)\247
30. Chebi:125612
31. Hms1685b19
32. Hms2051c11
33. Hms2232l05
34. Hms3393c11
35. (non-isotopelabelled)ipidacrine-d6
36. Albb-025742
37. Zinc6780651
38. Bbl003609
39. Bdbm50279987
40. Mfcd00618424
41. Stk520619
42. Akos000663960
43. Ccg-100784
44. Db13668
45. Hy-w027553
46. Mb01346
47. Nc00034
48. As-37850
49. Db-073181
50. Cs-0071577
51. Ft-0601640
52. Vu0254176-6
53. Brd-k66896231-001-06-5
54. Q15409425
55. F6170-0039
56. 2,3,5,6,7,8-hexahydro-1h-cyclopenta[b]quinoline-9-amine
57. 9-amino-2,3,5,6,7,8-hexahydro-1h-cyclopent[b]quinoline
58. 1h-cyclopenta(b)quinoline, 2,3,5,6,7,8-hexahydro-9-amino-
59. 9-amino-2,3,5,6,7,8-hexahydro-1h-cyclopenta[b]-quinoline
60. 1h-cyclopenta[b]quinolin-9-amine, 2,3,5,6,7,8-hexahydro-, Hydrochloride
| Molecular Weight | 188.27 g/mol |
|---|---|
| Molecular Formula | C12H16N2 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 188.131348519 g/mol |
| Monoisotopic Mass | 188.131348519 g/mol |
| Topological Polar Surface Area | 38.9 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 216 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
N - Nervous system
N06 - Psychoanaleptics
N06D - Anti-dementia drugs
N06DA - Anticholinesterases
N06DA05 - Ipidacrine
ABOUT THIS PAGE
72
PharmaCompass offers a list of Oprea1_177774 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oprea1_177774 manufacturer or Oprea1_177774 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oprea1_177774 manufacturer or Oprea1_177774 supplier.
PharmaCompass also assists you with knowing the Oprea1_177774 API Price utilized in the formulation of products. Oprea1_177774 API Price is not always fixed or binding as the Oprea1_177774 Price is obtained through a variety of data sources. The Oprea1_177774 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oprea1_177774 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oprea1_177774, including repackagers and relabelers. The FDA regulates Oprea1_177774 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oprea1_177774 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Oprea1_177774 supplier is an individual or a company that provides Oprea1_177774 active pharmaceutical ingredient (API) or Oprea1_177774 finished formulations upon request. The Oprea1_177774 suppliers may include Oprea1_177774 API manufacturers, exporters, distributors and traders.
Oprea1_177774 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oprea1_177774 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oprea1_177774 GMP manufacturer or Oprea1_177774 GMP API supplier for your needs.
A Oprea1_177774 CoA (Certificate of Analysis) is a formal document that attests to Oprea1_177774's compliance with Oprea1_177774 specifications and serves as a tool for batch-level quality control.
Oprea1_177774 CoA mostly includes findings from lab analyses of a specific batch. For each Oprea1_177774 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oprea1_177774 may be tested according to a variety of international standards, such as European Pharmacopoeia (Oprea1_177774 EP), Oprea1_177774 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oprea1_177774 USP).
